KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Gains from Sales and Divestitures (2016 - 2025)

HCA Healthcare (HCA) has disclosed Gains from Sales and Divestitures for 13 consecutive years, with $717000.0 as the latest value for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 12.21% year-over-year to $717000.0; the TTM value through Dec 2025 reached $717000.0, up 12.21%, while the annual FY2025 figure was $717000.0, 12.21% up from the prior year.
  • Gains from Sales and Divestitures hit $717000.0 in Q4 2025 for HCA Healthcare, up from $639000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $992000.0 in Q4 2021 and bottomed at $639000.0 in Q4 2024.
  • Average Gains from Sales and Divestitures over 5 years is $788600.0, with a median of $717000.0 recorded in 2023.
  • Year-over-year, Gains from Sales and Divestitures tumbled 58.56% in 2021 and then rose 12.21% in 2025.
  • HCA Healthcare's Gains from Sales and Divestitures stood at $992000.0 in 2021, then decreased by 11.49% to $878000.0 in 2022, then decreased by 18.34% to $717000.0 in 2023, then fell by 10.88% to $639000.0 in 2024, then increased by 12.21% to $717000.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $717000.0, $639000.0, and $717000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.